Israel PDA Chapter Invites you to
a Discussion Meeting on:

Moderated By  Karen Ginsbury
Lev Hakongressim building, Weizmann Science Park, Ness Ziona
Sunday  April 6 , 2008,  16:00h

Quality risk management is a systematic process for the assessment, control, communication and review of risks to the quality of the medicinal product.  With the:

1. formal adoption of ICH Q9 on Risk Management as Annex 20 of the EU GMPs and with
2. the incorporation of the Risk management approach in the  updated Chapter 1 of the EU GMPs

Israel PDA Chapter invites you to a discussion forum on the impacts that this will have on the manufacture of drug products.